The malevolent use of Anthrax spores on civilians in late 2001 has shown the necessity to protect European citizens from criminal use of biological agents and viruses. Although these attacks had been punctual and crude, more sophisticated attacks on dozens or hundreds of injured or killed people are conceivable. When launching such an attack its success depends on concentrating a sufficient amount ...